Liangxing Tu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Liangxing Tu has a total of 73 co-authors. Here are the top co-authors by number of shared publications:
Jianfang Feng
Jiangxi University of Chinese Medicine, Nanchang 330006, PR China; Guangxi University of Chinese Medicine, Nanning 530200, PR China
9 shared publications- Jianfang Feng
School of Pharmacy, Guangxi University of Chinese Medicine, Nanning 530200, China
8 shared publications Meng Cheng
8 shared publicationsYi Jin
Jiangxi University of Chinese Medicine, Nanchang 330006, PR China
8 shared publications- Meng Cheng
Jiangxi University of Chinese Medicine, Nanchang 330006, PR China
7 shared publications Wan Liu
National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Chinese Medicine
6 shared publications
Latest Publications
- 30 June 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 701, 127142
Approaches for enhancing bioavailability of macromolecular drugs
- 30 June 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 701, 127142
Approaches for enhancing bioavailability of macromolecular drugs
- 17 April 2026
- Published by Springer Nature in Phytochemistry Reviews
- Vol. 25  (6) , 1-26
Mechanisms of action of natural plant-derived bioactive compounds in treating intestinal tight junctions dysfunction
- 17 April 2026
- Published by Springer Nature in Phytochemistry Reviews
- Vol. 25  (6) , 1-26
Mechanisms of action of natural plant-derived bioactive compounds in treating intestinal tight junctions dysfunction
- 21 February 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 694, 126709
Overcoming the blood-brain barrier: the role of functionalized carbon dots in treating central nervous system diseases
- 21 February 2026
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 694, 126709
Overcoming the blood-brain barrier: the role of functionalized carbon dots in treating central nervous system diseases
- 4 February 2026
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 115  (7) , 104189
Enhancing transdermal drug delivery with dissolving microneedles: A review of optimization strategies and challenges
- 4 February 2026
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 115  (7) , 104189
Enhancing transdermal drug delivery with dissolving microneedles: A review of optimization strategies and challenges
- 6 December 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 688, 126459
Prodrug strategy: molecular design for improving oral drug absorption
- 6 December 2025
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 688, 126459
Prodrug strategy: molecular design for improving oral drug absorption
- Top Cited PapersOpen Access
- 29 January 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18  (2) , 183
Andrographolide Sulfonates and Xiyanping: A Review of Chemical Composition, Pharmacological Activities, Clinical Applications, and Adverse Reactions
Andrographis paniculata is a plant of the Acanthaceae family and its primary bioactive constituent, andrographolide, exhibits a broad spectrum of pharmacological activities and notable clinical efficacy. However, its poor solubility and limited bioavailability pose significant challenges for therapeutic applications. To overcome these limitations, researchers have synthesized andrographolide sulfonates by reacting andrographolide with ethanol and sulfuric acid. This sulfonated derivative significantly enhances water solubility and bioavailability while retaining key pharmacological properties such as anti-inflammatory and antiviral activities. As a representative formulation, Xiyanping injection has been widely employed in the treatment of respiratory infections, pneumonia, and related conditions, playing a critical role during the COVID-19 pandemic. Despite its widespread application, there has yet to be a comprehensive review of its chemical composition and pharmacological mechanisms. Additionally, the safety of Xiyanping injection remains a topic of some debate. This review systematically examines the chemical composition, pharmacological activities, clinical applications, and adverse reactions of andrographolide sulfonates and their formulation in Xiyanping injection to provide a scientific basis for further research and applications, while also offering valuable insights for the development of similar sulfonated drugs.
- 29 January 2025
- Published by MDPI AG in Pharmaceuticals
- Vol. 18  (2) , 183
Top Cited PapersOpen AccessAndrographolide Sulfonates and Xiyanping: A Review of Chemical Composition, Pharmacological Activities, Clinical Applications, and Adverse Reactions
Andrographis paniculata is a plant of the Acanthaceae family and its primary bioactive constituent, andrographolide, exhibits a broad spectrum of pharmacological activities and notable clinical efficacy. However, its poor solubility and limited bioavailability pose significant challenges for therapeutic applications. To overcome these limitations, researchers have synthesized andrographolide sulfonates by reacting andrographolide with ethanol and sulfuric acid. This sulfonated derivative significantly enhances water solubility and bioavailability while retaining key pharmacological properties such as anti-inflammatory and antiviral activities. As a representative formulation, Xiyanping injection has been widely employed in the treatment of respiratory infections, pneumonia, and related conditions, playing a critical role during the COVID-19 pandemic. Despite its widespread application, there has yet to be a comprehensive review of its chemical composition and pharmacological mechanisms. Additionally, the safety of Xiyanping injection remains a topic of some debate. This review systematically examines the chemical composition, pharmacological activities, clinical applications, and adverse reactions of andrographolide sulfonates and their formulation in Xiyanping injection to provide a scientific basis for further research and applications, while also offering valuable insights for the development of similar sulfonated drugs.
- Open Access
- 8 November 2024
- Published by Georg Thieme Verlag KG in Pharmaceutical Fronts
- Vol. 06  (04) , e439-e448
Resveratrol-Loaded Dissolving Microneedles: Fabrication and in vitro Evaluation
Resveratrol (Res), an active ingredient derived from a multitude of plants, exhibits multiple pharmacological activities. However, its poor water solubility and low bioavailability present significant challenges to its clinical application. Our study aimed to improve the transdermal absorption of Res using dissolving microneedle (MN) technology, which could effectively overcome the stratum corneum barrier. Res-loaded dissolving microneedles (Res-MNs) were fabricated using polyvinyl pyrrolidone K90 (PVP K90) as the matrix material, and a two-step casting procedure was employed. The process was optimized using the Box–Behnken experimental design approach. The characteristics of Res-MNs in vitro, including morphology, solubility, safety evaluation, and skin permeation, were studied. The results showed that the optimum preparation conditions of Res-MNs were a centrifugation time of 10 minutes, a solvent concentration of 25%, and a prescription ratio (Res: matrix) of 0.375. The skin permeability of the Res-MNs was enhanced compared with Res suspension and Res gel. The cumulative release of Res-MNs in vitro was 75%, which was approximately 5 and 3 times that of the Res suspension group and Res gel group. These results suggest that dissolving MNs may represent a potential approach for enhancing the transdermal delivery of poorly absorbed drugs such as Res.
- 8 November 2024
- Published by Georg Thieme Verlag KG in Pharmaceutical Fronts
- Vol. 06  (04) , e439-e448
Open AccessResveratrol-Loaded Dissolving Microneedles: Fabrication and in vitro Evaluation
Resveratrol (Res), an active ingredient derived from a multitude of plants, exhibits multiple pharmacological activities. However, its poor water solubility and low bioavailability present significant challenges to its clinical application. Our study aimed to improve the transdermal absorption of Res using dissolving microneedle (MN) technology, which could effectively overcome the stratum corneum barrier. Res-loaded dissolving microneedles (Res-MNs) were fabricated using polyvinyl pyrrolidone K90 (PVP K90) as the matrix material, and a two-step casting procedure was employed. The process was optimized using the Box–Behnken experimental design approach. The characteristics of Res-MNs in vitro, including morphology, solubility, safety evaluation, and skin permeation, were studied. The results showed that the optimum preparation conditions of Res-MNs were a centrifugation time of 10 minutes, a solvent concentration of 25%, and a prescription ratio (Res: matrix) of 0.375. The skin permeability of the Res-MNs was enhanced compared with Res suspension and Res gel. The cumulative release of Res-MNs in vitro was 75%, which was approximately 5 and 3 times that of the Res suspension group and Res gel group. These results suggest that dissolving MNs may represent a potential approach for enhancing the transdermal delivery of poorly absorbed drugs such as Res.
- 18 October 2024
- Published by Elsevier in Chinese Chemical Letters
- Vol. 36  (5)
Intestinal transporters and oral absorption enhancing strategies based on these transporters
- 18 October 2024
- Published by Elsevier in Chinese Chemical Letters
- Vol. 36  (5)
Intestinal transporters and oral absorption enhancing strategies based on these transporters
- 5 September 2024
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 25  (7) , 1-16
Fabrication of Luteolin Nanoemulsion by Box-Behnken Design to Enhance its Oral Absorption Via Lymphatic Transport
Intestinal lymphatic transport offers an alternative and effective way to deliver drugs, such as avoiding first-pass metabolism, enhancing oral bioavailabi
- 5 September 2024
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 25  (7) , 1-16
Fabrication of Luteolin Nanoemulsion by Box-Behnken Design to Enhance its Oral Absorption Via Lymphatic Transport
Intestinal lymphatic transport offers an alternative and effective way to deliver drugs, such as avoiding first-pass metabolism, enhancing oral bioavailabi
- 21 September 2023
- Published by Elsevier in Chinese Chemical Letters
- Vol. 35  (7)
Vesicular drug delivery systems for oral absorption enhancement
- 21 September 2023
- Published by Elsevier in Chinese Chemical Letters
- Vol. 35  (7)
Vesicular drug delivery systems for oral absorption enhancement